Literature DB >> 28504884

d-α-Tocopheryl Succinate/Phosphatidyl Ethanolamine Conjugated Amphiphilic Polymer-Based Nanomicellar System for the Efficient Delivery of Curcumin and To Overcome Multiple Drug Resistance in Cancer.

Omkara Swami Muddineti1, Preeti Kumari1, Balaram Ghosh1, Vladimir P Torchilin2, Swati Biswas1.   

Abstract

Nanomedicines have emerged as a promising treatment strategy for cancer. Multiple drug resistance due to overexpression of various drug efflux transporters and upregulation of apoptotic inhibitory pathways in cancer cells are major barriers that limit the success of chemotherapy. Here, we developed a d-α-tocopherol (α-TOS)/lipid-based copolymeric nanomicellar system (VPM) by conjugating phosphatidyl ethanolamine (PE) and α-TOS with poly(ethylene glycol) (PEG) via an amino acid linkage. The synthesized polymers were characterized by Fourier transform IR, gas-phase chromatography, and 1H and 13C NMR spectroscopy. VPM exhibited mean hydrodynamic diameter of 141.0 ± 0.94 nm with low critical micelles concentrations (CMC) of 15 μM compared to plain PEG-PE micelles (PPM) with size of 23.9 ± 0.34 nm and CMC 20 μM. The bigger hydrophobic compartment in VPM resulted in improved loading of a potent chemotherapeutic drug, curcumin (Cur), and increased encapsulation efficiency (EE) (% drug loading 98.3 ± 1.92, and 85.3 ± 3.29; EE 14.8 ± 0.16 and 12.8 ± 0.09 for VPM and PPM, respectively). Curcumin loaded Vitamin E based micelles exhibited higher cytotoxicity compared to Curcumin loaded PEG-PE micelles in tested cancer cell lines. C-VPM demonstrated ∼3.2 and ∼2.7-fold higher ability to reverse multiple drug resistance compared to PPM and verapamil (concentration used 30 μM), respectively. In the in vivo study by using B16F10 implanted C57Bl6/J mice, C-VPM reduced the tumor volume and weight more efficiently than C-PPM by inducing apoptosis as analyzed by TUNEL assay on tumor cryosections. The newly developed polymeric micelles, VPM with improved drug loadability and ability to reverse the drug resistance could successfully be utilized as a nanocarrier system for hydrophobic chemotherapeutic agents for the treatment of drug-resistant solid tumors.

Entities:  

Keywords:  P-glycoprotein; cancer; curcumin; multidrug resistance; phosphatidyl ethanolamine; α-TOS

Mesh:

Substances:

Year:  2017        PMID: 28504884     DOI: 10.1021/acsami.7b01087

Source DB:  PubMed          Journal:  ACS Appl Mater Interfaces        ISSN: 1944-8244            Impact factor:   9.229


  8 in total

1.  Transferrin/α-tocopherol modified poly(amidoamine) dendrimers for improved tumor targeting and anticancer activity of paclitaxel.

Authors:  Himanshu Bhatt; Sri Vishnu Kiran Rompicharla; Balaram Ghosh; Vladimir Torchilin; Swati Biswas
Journal:  Nanomedicine (Lond)       Date:  2019-12       Impact factor: 5.307

2.  Poly(N-vinylcaprolactam) containing solid lipid polymer hybrid nanoparticles for controlled delivery of a hydrophilic drug gemcitabine hydrochloride.

Authors:  Sai Geetika Surapaneni; Ashootosh V Ambade
Journal:  RSC Adv       Date:  2022-06-14       Impact factor: 4.036

3.  Transferrin-Modified Vitamin-E/Lipid Based Polymeric Micelles for Improved Tumor Targeting and Anticancer Effect of Curcumin.

Authors:  Omkara Swami Muddineti; Preeti Kumari; Balaram Ghosh; Swati Biswas
Journal:  Pharm Res       Date:  2018-03-14       Impact factor: 4.200

4.  pH-triggered surface charge-switchable polymer micelles for the co-delivery of paclitaxel/disulfiram and overcoming multidrug resistance in cancer.

Authors:  Qiang Huo; Jianhua Zhu; Yimin Niu; Huihui Shi; Yaxiang Gong; Yang Li; Huihui Song; Yang Liu
Journal:  Int J Nanomedicine       Date:  2017-12-04

5.  An α-tocopheryl succinate enzyme-based nanoassembly for cancer imaging and therapy.

Authors:  Song Yi Lee; Hyun-Jong Cho
Journal:  Drug Deliv       Date:  2018-11       Impact factor: 6.419

6.  Adjudin-loaded redox-sensitive paclitaxel-prodrug micelles for overcoming multidrug resistance with efficient targeted Colon cancer therapy.

Authors:  Deli Chen; Sitang Ge; Lugen Zuo; Shuanhu Wang; Mulin Liu; Shiqing Li
Journal:  Drug Deliv       Date:  2020-12       Impact factor: 6.419

7.  Artificially controlled degradable nanoparticles for contrast switch MRI and programmed cancer therapy.

Authors:  Tianyang Yun; Yuxin Liu; Shaoqiong Yi; Qi Jia; Yang Liu; Jing Zhou
Journal:  Int J Nanomedicine       Date:  2018-10-24

Review 8.  Upconversion Nanostructures Applied in Theranostic Systems.

Authors:  Chao Lu; Etienne Joulin; Howyn Tang; Hossein Pouri; Jin Zhang
Journal:  Int J Mol Sci       Date:  2022-08-12       Impact factor: 6.208

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.